NOBEL MEDICUS, cilt.10, sa.2, ss.44-49, 2014 (SCI-Expanded)
Objective: Invasive aspergillosis (IA) is associated with an unacceptably high mortality rate. Early diagnosis is critical to a favourable outcome, but it is difficult to achieve with conventional methods. For these reasons, a range of alternate diagnostic strategies have been investigated. It was aimed to evaluate the diagnostic potential of the galactomannan (GM), 1, 3 beta-D-glucan (BDG) for IA.